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In meta-analyses, when data are pooled and analyzed using
random effect models, it is standard to report a confidence
interval (CI) around the effect estimate [1–3], as reported
in several meta-analyses published in the European Jour-
nal of Epidemiology [4–6]. Nevertheless, when heteroge-
neity is substantial, some authors have proposed to report a
prediction interval (PI) rather than a CI to have a better
appreciation of the uncertainty around the effect estimate
[7–9].
What is the meaning of confidence and prediction
intervals? Using results from a meta-analysis demonstrat-
ing the impact of pharmacist interventions on blood pres-
sure [10], we explain how to use each of these intervals.
In a recent systematic review with meta-analyses of ran-
domized controlled trials, we showed that pharmacist inter-
ventions improve the management of major cardiovascular
disease risk factors in outpatients, including hypertension,
dyslipidemia, and smoking [10]. Interventions were led by
the pharmacist alone or in collaboration with other health
professionals (e.g., physicians or nurses) and included
patient educational interventions, measurement of blood
pressure, medication management and feedback to physi-
cian, or educational interventions to healthcare profession-
als. Heterogeneity in the effect of interventions was expected
and random effects models were used to estimate mean
changes in blood pressure [2].
Out of 30 trials included in this review, blood pressure was
the outcome in 19 studies including 10,479 patients. Phar-
macist interventions were associated with clinically and
statistically significant reductions of systolic (-8.1 mmHg
[95 % CI -10.2 to -5.9]) (Fig. 1) and diastolic blood
pressure (-3.8 mmHg [95 % CI -5.3 to -2.3]) (Fig. 2)
compared with usual care. Nevertheless, a substantial het-
erogeneity was observed in the effect of pharmacist inter-
ventions for both systolic (I2 = 76 %; I2 is a measure of
between study heterogeneity not due to chance [2]) and
diastolic blood pressure (I2 = 85 %). Differences between
studies in terms of type and intensity of interventions may
explain this heterogeneity [10, 11]. We computed PI and CI
for the effect estimate of pharmacist interventions on blood
pressure (Table 1).
For both systolic and diastolic blood pressure, PI was
much wider than CI. It is critical to realize that CI and PI do
not estimate the same thing [8, 9]. CI quantifies the accuracy
of the mean and indicates where the mean effect is likely to
be [8]. More particularly in our meta-analysis, CI indicates
the uncertainty around the estimate of the average effect of
pharmacist interventions. Since CI for systolic and CI for
diastolic blood pressure do not contain the null value
(Table 1), we are confident that the effect on blood pressure
is on average beneficial [2]. PI quantifies the dispersion (or
distribution) of effect estimates of the interventions [8]. It
means that in 95 % of cases the true effect of a new and
unique study (from the same family of studies assessing the
impact of a pharmacist intervention) will fall within the PI
values. In our case, the PI contains values close to 0 mmHg
for systolic blood pressure and above 0 mmHg for diastolic
blood pressure (Table 1). This means that, although phar-
macists’ interventions are effective on average to decrease
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blood pressure, some of these interventions may not be
effective. On the other hand, each PI also contains largely
negative values underlining that some pharmacist inter-
ventions could have a very large effect on blood pressure.
In conclusion, CI and PI convey different but comple-
mentary information. While our results indicate with high
confidence that, on average, pharmacist interventions
decrease blood pressure, they should also drive researchers
to conduct further studies to determine which type of
pharmacist intervention is the most effective to decrease
blood pressure.
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Fig. 1 Forest plot of the mean difference in systolic blood pressure
with pharmacist care compared with usual care group. The diamond
represents confidence interval (CI) around the effect estimate. The
prediction interval (PI) is shown with lines extending from the
diamond. WMD: weighted mean difference. Data are adapted from
Santschi et al. [10]
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Fig. 2 Forest plot of the mean difference in diastolic blood pressure
with pharmacist care compared with usual care group. The diamond
represents confidence interval (CI) around the effect estimate. The
prediction interval (PI) is shown with lines extending from the
diamond. WMD: weighted mean difference. Data are adapted from
Santschi et al. [10]
Table 1 Effect estimate of pharmacist interventions on systolic and
diastolic blood pressure
Mean
effect
95 %
confidence
interval
95 %
prediction
interval
Systolic blood
pressure [mmHg]
-8.1 -10.2 to –5.9 -16.1 to 0.0
Diastolic blood
pressure [mmHg]
-3.8 -5.3 to –2.3 -10.0 to ?2.4
Data are pooled from 19 studies including 10,479 patients (adapted
from Santschi et al. [10])
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